BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16274700)

  • 21. Plant natural products: back to the future or into extinction?
    McChesney JD; Venkataraman SK; Henri JT
    Phytochemistry; 2007 Jul; 68(14):2015-22. PubMed ID: 17574638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale phenotyping of transgenic tobacco plants (Nicotiana tabacum) to identify essential leaf functions.
    Lein W; Usadel B; Stitt M; Reindl A; Ehrhardt T; Sonnewald U; Börnke F
    Plant Biotechnol J; 2008 Apr; 6(3):246-63. PubMed ID: 18086234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plants with neurobiological activity as potential targets for drug discovery.
    Gomes NG; Campos MG; Orfão JM; Ribeiro CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1372-89. PubMed ID: 19666075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ex-vivo angiogenesis assay as a screening method for natural compounds and herbal drug preparations.
    Baróniková S; Apers S; Vanden Berghe D; Cos P; Vermeulen P; Van Daele A; Pieters L; Van Marck E; Vlietinck A
    Planta Med; 2004 Oct; 70(10):887-92. PubMed ID: 15490313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators.
    Bremner P; Rivera D; Calzado MA; Obón C; Inocencio C; Beckwith C; Fiebich BL; Muñoz E; Heinrich M
    J Ethnopharmacol; 2009 Jul; 124(2):295-305. PubMed ID: 19397975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated expressional analysis: application to the drug discovery process.
    Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
    Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncovering the therapeutic potential of natural products with biomarker-guided screening.
    Kawamura A
    IDrugs; 2010 May; 13(5):321-4. PubMed ID: 20432189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of active compounds from medicinal plant extracts using gas chromatography-mass spectrometry and multivariate data analysis.
    Ching J; Soh WL; Tan CH; Lee JF; Tan JY; Yang J; Yap CW; Koh HL
    J Sep Sci; 2012 Jan; 35(1):53-9. PubMed ID: 22127806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection methodology with scoring system: application to Mexican plants producing podophyllotoxin related lignans.
    Lautié E; Quintero R; Fliniaux MA; Villarreal ML
    J Ethnopharmacol; 2008 Dec; 120(3):402-12. PubMed ID: 18930796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of Indian plants for biological activity: Part XV.
    Aswal BS; Goel AK; Kulshrestha DK; Mehrotra BN; Patnaik GK
    Indian J Exp Biol; 1996 May; 34(5):444-67. PubMed ID: 9063078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method.
    Zaidan MR; Noor Rain A; Badrul AR; Adlin A; Norazah A; Zakiah I
    Trop Biomed; 2005 Dec; 22(2):165-70. PubMed ID: 16883283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytotherapeutics: an evaluation of the potential of 1000 plants.
    Cravotto G; Boffa L; Genzini L; Garella D
    J Clin Pharm Ther; 2010 Feb; 35(1):11-48. PubMed ID: 20175810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fluorescence polarization assay to quantify biotin and biotin-binding proteins in whole plant extracts using Alexa-Fluor 594 biocytin.
    Martin H; Murray C; Christeller J; McGhie T
    Anal Biochem; 2008 Oct; 381(1):107-12. PubMed ID: 18611389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural products as a screening resource.
    Harvey AL
    Curr Opin Chem Biol; 2007 Oct; 11(5):480-4. PubMed ID: 17884696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Mycobacterium marinum zone of inhibition assay as a method for screening potential antimycobacterial compounds from marine extracts.
    Barker LP; Lien BA; Brun OS; Schaak DD; McDonough KA; Chang LC
    Planta Med; 2007 Jun; 73(6):559-63. PubMed ID: 17534789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESbetaL-producing multidrug-resistant enteric bacteria.
    Ahmad I; Aqil F
    Microbiol Res; 2007; 162(3):264-75. PubMed ID: 16875811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for ligands using a generic and high-throughput light-scattering-based assay.
    Senisterra GA; Markin E; Yamazaki K; Hui R; Vedadi M; Awrey DE
    J Biomol Screen; 2006 Dec; 11(8):940-8. PubMed ID: 17092916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.